Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004564109 | SCV000552698 | likely benign | Familial adenomatous polyposis 1 | 2025-01-02 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000583952 | SCV000686951 | likely benign | Hereditary cancer-predisposing syndrome | 2017-11-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000583952 | SCV001182612 | likely benign | Hereditary cancer-predisposing syndrome | 2019-09-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Myriad Genetics, |
RCV004564109 | SCV004930580 | benign | Familial adenomatous polyposis 1 | 2024-03-22 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |